Last updated: July 10, 2026

Application No. 19/533,985

Untitled Application

Unknown

Filed

Priority

Oct 12, 2022 — provisional 63/415,526 +4 more

Examiner

REDDIG, PETER J

Art Unit

Tech Center

MERCK SHARP & DOHME LLC

Assignee

Merck Sharp & Dohme LLC

OA Round

1 (Non-Final)

This examiner grants 58% of cases after interview

— +40.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1025 resolved cases, 2023–2026

Examiner Intelligence

REDDIG, PETER J View full profile →

Grants 58% of resolved cases

Career Allowance Rate

595 granted / 1025 resolved

-2.0% vs TC avg

Strong +40% interview lift

Without

With

+40.1%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

57 currently pending

Career history

1073

Total Applications

across all art units

Statute-Specific Performance

§101

2.4%

-37.6% vs TC avg

§103

32.8%

-7.2% vs TC avg

§102

13.8%

-26.2% vs TC avg

§112

18.1%

-21.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1025 resolved cases

Prosecution Timeline

Apr 15, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

16/021,777

Patent 12673993

Functional Antibody Fragment Complementation for a Two-Components System for Redirected Killing of Unwanted Cells

8y 0m to grant Granted Jul 07, 2026

17/904,941

Patent 12673980

ENGINEERED T CELL RECEPTORS AND METHODS OF USE

3y 10m to grant Granted Jul 07, 2026

18/056,572

Patent 12674180

CD8-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS THEREOF

3y 7m to grant Granted Jul 07, 2026

18/331,862

Patent 12643953

ANTI-CD20 ANTIBODY AND USES THEREOF

2y 12m to grant Granted Jun 02, 2026

17/791,415

Patent 12624090

METHOD AND ANTIBODY FOR DETECTION OF HBCAG

3y 10m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

58%

Grant Probability

98%

With Interview (+40.1%)

3y 5m

Median Time to Grant

Low

PTA Risk

Based on 1025 resolved cases by this examiner. Grant probability derived from career allowance rate.